Viewing Study NCT04862767


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2025-12-26 @ 1:13 PM
Study NCT ID: NCT04862767
Status: COMPLETED
Last Update Posted: 2024-01-31
First Post: 2021-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor
Sponsor: Autotelicbio
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module